Biotech Growth Trust: A Compelling Entry Point for Long-Term Investors?
It has been a difficult period for investors in small cap biotech stocks, which have suffered a huge write down…
It has been a difficult period for investors in small cap biotech stocks, which have suffered a huge write down…
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
With interims next Monday, Mark Watson-Mitchell says that the shares are cheap trading at 6.7 times earnings.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
As many as five million British workers have either taken early retirement since the pandemic or are on long-term sick…
Mark Watson-Mitchell catches up with the news on some of his favourite stocks ahead of the weekend.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
Mark Watson-Mitchell profiles a few of his favourite stocks.
It has been another tough period for Scottish Mortgage, with the trust reporting a 15% loss in the six months…